Journal articleJ Nucl Med2026

[177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies.

DOI 10.2967/jnumed.125.271705 ↗ pmc_oa, retrieved 5 November 2026

Journal: J Nucl Med
Published: 2 September 2026
Citations: 1
Type: Article
License: cc by
Full text: Open access, reuse-licensed (cc by)

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try